APA (7th ed.) Citation

Kratochwil, C., Afshar-Oromieh, A., Haberkorn, U., & Giesel, F. L. (2016). Current status of prostate-specific membrane antigen targeting in nuclear medicine: Clinical translation of chelator containing prostate-specific membrane antigen ligands into diagnostics and therapy for prostate cancer. Seminars in nuclear medicine, 46(5), . https://doi.org/10.1053/j.semnuclmed.2016.04.004

Chicago Style (17th ed.) Citation

Kratochwil, Clemens, Ali Afshar-Oromieh, Uwe Haberkorn, and Frederik L. Giesel. "Current Status of Prostate-specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-specific Membrane Antigen Ligands into Diagnostics and Therapy for Prostate Cancer." Seminars in Nuclear Medicine 46, no. 5 (2016). https://doi.org/10.1053/j.semnuclmed.2016.04.004.

MLA (9th ed.) Citation

Kratochwil, Clemens, et al. "Current Status of Prostate-specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-specific Membrane Antigen Ligands into Diagnostics and Therapy for Prostate Cancer." Seminars in Nuclear Medicine, vol. 46, no. 5, 2016, https://doi.org/10.1053/j.semnuclmed.2016.04.004.